共 182 条
[11]
Fujiki Y(2015)The relation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume with the presence and severity of Behcet's syndrome Kaohsiung J Med Sci 13 881-310
[12]
Kotani T(2017)Can we use the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume values for the diagnosis of anterior uveitis in patients with Behcet’s disease? Ther Clin Risk Manag 43 305-99
[13]
Isoda K(2016)Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis J Dermatol 36 94-9414
[14]
Ishida T(2016)Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus Int Immunopharmacol 10 9406-1570
[15]
Shoda T(2021)Neutrophil-to-lymphocyte ratios and platelet-to-lymphocyte ratios in juvenile systemic lupus erythematosus: correlation with disease manifestations Ann Palliat Med 51 1563-2119
[16]
Yoshida S(2012)Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis Rheumatology 57 2114-521
[17]
Takeuchi T(2018)Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis Rheumatology 33 e22978-791
[18]
Makino S(2019)Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease J Clin Lab Anal 58 511-157
[19]
Mammen AL(2019)CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease Rheumatology 58 786-266
[20]
Allenbach Y(2019)The relationship between type 1 IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients Rheumatology 39 151-3525